经验

Smart Share Global – $150 Million IPO

March 31, 2021

Cooley advised the underwriters on Smart Share Global’s $150 million initial public offering of 17,650,000 American Depositary Shares. Goldman Sachs, Citigroup Global Markets  and China Renaissance Securities (Hong Kong) Limited acted as joint bookrunners and for the offering. Smart Share Global, whose securities now trade on the Nasdaq Global Select Market under the symbol EM, is a consumer tech company providing mobile device charging service. Partners Will Cai, Michael Yu and David Peinsipp led the Cooley team.

Related contacts

蔡华
合伙人, 香港
余仙
香港办事处主管合伙人, 香港
David Peinsipp
Partner, 旧金山
Josh Kaufman
Partner, 纽约
李正洋
法律助理, 香港
张捷
合伙人, 香港

Related Practices & Industries

TI Cloud – HK$559.4 Million IPO

July 1, 2022

Cooley advised TI Cloud, a cloud-native customer contact solution provider, on its HK$559.4 million ($71.7 million) initial public offering of 43,530,000 shares (subject to an overallotment option to issue an additional 6,529,400 shares), which now trade on the Hong Kong Stock Exchange. Partners Michael Yu and Will Cai led the Cooley team advising TI Cloud, which also included Jie Zhang, Ying Liu, Keke Wu, Zhengyang Li, Lingyi Lin and Philip Kwan. 
Read more

Related contacts

余仙
香港办事处主管合伙人, 香港
蔡华
合伙人, 香港
Xander Lee
Partner, 洛杉矶
Francis Wheeler
Partner, 科罗拉多
张捷
合伙人, 香港
刘颖
律师, 香港
李正洋
法律助理, 香港
Rick Jantz
Associate, 洛杉矶
Philip Kwan
Senior Legal Assistant, 香港

Related Practices & Industries

Cryofocus Medtech – HK$210 Million IPO

January 5, 2023

Cooley advised the joint sponsors and underwriters of Cryofocus Medtech’s HK$210 million ($27 million) initial public offering of 11,110,000 H Shares on the Hong Kong Stock Exchange.
Read more

Related contacts

余仙
香港办事处主管合伙人, 香港
刘毅铭
上海办事处主管合伙人, 上海
蔡华
合伙人, 香港
杨凯婷
律师, 香港
王一盈
律师, 上海
徐云翔
律师, 上海
Brian Lau
International Legal Project Manager, 香港
吴茜
国际法律项目经理, 上海
李正洋
法律助理, 香港

ImmuneOnco Biopharmaceuticals – HK$319 Million IPO

September 5, 2023

Cooley advised ImmuneOnco Biopharmaceuticals, a clinical-stage biotechnology company dedicated to the development of immuno-oncology therapies, on its HK$319 million initial public offering.

Read more

Related contacts

刘毅铭
上海办事处主管合伙人, 上海
余仙
香港办事处主管合伙人, 香港
Xander Lee
Partner, 洛杉矶
Francis Wheeler
Partner, 科罗拉多
Eric Blanchard
Partner, 纽约
王一盈
律师, 上海
杨凯婷
律师, 香港
徐云翔
律师, 上海
徐潇雨
律师, 北京
白雪
律师, 上海
Rick Jantz
Associate, 洛杉矶
Cindy Pan
International Legal Project Manager, 香港
吴茜
国际法律项目经理, 上海
杨忆菁
法律助理, 上海
李正洋
法律助理, 香港

Related Practices & Industries

Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by Syndicate of Premier Healthcare Investors

August 9, 2023

Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of cancer and autoimmune diseases, on its private placement financing of up to $150 million.

Read more

Related contacts

蔡华
合伙人, 香港
张捷
合伙人, 香港
Francis Wheeler
Partner, 科罗拉多
李涵
注册外国律师(纽约), 香港
姚植洪
律师, 香港
Samantha Zhang
Associate, 新加坡
李正洋
法律助理, 香港

Related Practices & Industries